Alaa Assem, Managing Director for CTI in the Europe & MEA regions, joins us to discuss the evolution of clinical trials in the Middle East and Africa. With over a decade of experience in pharma and CROs, Alaa shares how CTI has built a strong regional presence, the impact of COVID-19, and why sponsors should consider the region for future trials.
Topics Covered:
Timestamps:
- 00:00 – Meet Alaa and his background
- 00:56 – CTI’s regional roots and growth
- 02:19 – Why local presence matters
- 03:20 – Clinical research evolution in the region
- 05:02 – COVID-19’s transformative impact
- 06:44 – Vaccine research and biotech hubs
- 08:33 – Advice for sponsors entering the region
- 10:33 – Changing perceptions and realities
- 12:52 – CTI’s readiness and expansion strategy
- 14:06 – Future growth and innovation
- 15:42 – Alaa’s excitement for the future of research
